| 246.81 -3.6 (-1.44%) | 04-25 15:03 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 299.6 | 1-year : | 349.93 |
| Resists | First : | 256.51 | Second : | 299.6 |
| Pivot price | 243.04  |
|||
| Supports | First : | 240.58 | Second : | 230.74 |
| MAs | MA(5) : | 244.35 |
MA(20) : | 243.76  |
| MA(100) : | 240.29 |
MA(250) : | 224.53 |
|
| MACD | MACD : | -1 |
Signal : | -1.9 |
| %K %D | K(14,3) : | 77.4 |
D(3) : | 63.4 |
| RSI | RSI(14): 51.9 |
|||
| 52-week | High : | 259 | Low : | 182.08 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ DHR ] has closed below upper band by 32.9%. Bollinger Bands are 40% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 254.36 - 255.82 | 255.82 - 257.14 |
| Low: | 244.65 - 246.23 | 246.23 - 247.66 |
| Close: | 248.12 - 250.67 | 250.67 - 252.97 |
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Thu, 25 Apr 2024
Q3 2024 EPS Estimates for Danaher Co. Reduced by Analyst (NYSE:DHR) - MarketBeat
Thu, 25 Apr 2024
Value Vs. Growth? Danaher Says Why Not Both? (NYSE:DHR) - Seeking Alpha
Wed, 24 Apr 2024
Danaher Corp. stock falls Wednesday, underperforms market - MarketWatch
Wed, 24 Apr 2024
Danaher Corporation (NYSE:DHR) Q1 2024 Earnings Call Transcript - Yahoo Finance
Wed, 24 Apr 2024
Decoding Danaher Corp (DHR): A Strategic SWOT Insight - Yahoo Canada Finance
Tue, 23 Apr 2024
Danaher: Q1 Earnings Snapshot - Darien Times
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 741 (M) |
| Shares Float | 659 (M) |
| Held by Insiders | 10.7 (%) |
| Held by Institutions | 81.6 (%) |
| Shares Short | 6,350 (K) |
| Shares Short P.Month | 6,070 (K) |
| EPS | 5.65 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 72.36 |
| Profit Margin | 19.9 % |
| Operating Margin | 20.8 % |
| Return on Assets (ttm) | 3.9 % |
| Return on Equity (ttm) | 8.1 % |
| Qtrly Rev. Growth | -23.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 32.26 |
| EBITDA (p.s.) | 10.19 |
| Qtrly Earnings Growth | -51.3 % |
| Operating Cash Flow | 7,160 (M) |
| Levered Free Cash Flow | 4,860 (M) |
| PE Ratio | 43.65 |
| PEG Ratio | 10.3 |
| Price to Book value | 3.4 |
| Price to Sales | 7.64 |
| Price to Cash Flow | 25.51 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|